WEBINAR: INNOVATIVE ENDPOINTS IN ALZHEIMER’S DISEASE CLINICAL TRIALS

DECEMBER 7 / 17.00 CET

Together with our partner Brain Research Center, we present the webinar:

Innovative Endpoints in Alzheimer’s Disease Clinical Trials.

We are pleased to announce that this webinar will be presented by:
Dr. Niels Prins and Dr. Jort Vijverberg.

Dr. Niels Prins and Dr. Jort Vijverberg will expand on how we advance clinical drug development for Alzheimer’s disease by touching upon:
> Biomarker-based participant selection in AD trials
> Fluid biomarkers as endpoints in AD trials.
> EEG; a ‘novel’ AD biomarker.

Don’t miss this opportunity and register now.

More information about Brain Research Center, you will find below.